Research

Our research scope reflects the breadth of endocrine-related disease.

Major diseases studied include diabetes mellitus and its complications, thyroid disease (including cancer and Graves' disease), adrenal disease, and pituitary disease. Morbid obesity and its management is a significant area of research, with particular interest in people with obesity and mental illness and intellectual delay, and genetic disorders such as Prader-Willi syndrome).

Research teams conduct clinical intervention studies, clinical audit and health care delivery research.

Laboratory-based translational research (including biomarker studies of human samples), and testing of findings and potential mediators of disease in preclinical (animal and cell-based) models is also undertaken.

Studies can be driven by clinicians (Investigator) or sponsored by biopharmaceutical or biotechnology partners. We collaborate with other leaders in endocrinology research involving areas such as liver, heart, immune and kidney disease, to try and improve patient health outcomes together.

Research is funded by competitive grant funding and generous philanthropic donations.

On average, we collectively publish more than 50 scientific papers each year.

Each year we supervise around 10 postgraduate (PhD and Masters) students. As a reflection of the emerging diversity of endocrinology concerns, students come from diverse backgrounds, including science, medicine sub areas, nursing, podiatry, psychology, engineering, and exercise physiology.

View our latest quarterly RPA Hospital Endocrinology Research Activity Report.